A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder

Autor: Kim, Eun Young, Kim, Se Hyun, Lee, Hyun Jeong, Lee, Nam Young, Kim, Hye Young, Park, C. Hyung Keun, Ahn, Yong Min
Zdroj: In Journal of Affective Disorders 1 December 2019 259:91-97
Databáze: ScienceDirect
Externí odkaz: